You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ETHAMBUTOL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ethambutol Hydrochloride patents expire, and when can generic versions of Ethambutol Hydrochloride launch?

Ethambutol Hydrochloride is a drug marketed by Barr, Epic Pharma Llc, and Lupin. and is included in three NDAs.

The generic ingredient in ETHAMBUTOL HYDROCHLORIDE is ethambutol hydrochloride. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ethambutol Hydrochloride

A generic version of ETHAMBUTOL HYDROCHLORIDE was approved as ethambutol hydrochloride by EPIC PHARMA LLC on November 30th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ETHAMBUTOL HYDROCHLORIDE?
  • What are the global sales for ETHAMBUTOL HYDROCHLORIDE?
  • What is Average Wholesale Price for ETHAMBUTOL HYDROCHLORIDE?
Summary for ETHAMBUTOL HYDROCHLORIDE
US Patents:0
Applicants:3
NDAs:3
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 121
Clinical Trials: 118
Patent Applications: 4,554
What excipients (inactive ingredients) are in ETHAMBUTOL HYDROCHLORIDE?ETHAMBUTOL HYDROCHLORIDE excipients list
DailyMed Link:ETHAMBUTOL HYDROCHLORIDE at DailyMed
Drug patent expirations by year for ETHAMBUTOL HYDROCHLORIDE
Recent Clinical Trials for ETHAMBUTOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
FindPhase 2
LMU University Hospital MunichPhase 2
University of California, San FranciscoPhase 2

See all ETHAMBUTOL HYDROCHLORIDE clinical trials

Pharmacology for ETHAMBUTOL HYDROCHLORIDE
Drug ClassAntimycobacterial
Medical Subject Heading (MeSH) Categories for ETHAMBUTOL HYDROCHLORIDE

US Patents and Regulatory Information for ETHAMBUTOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 076057-001 Nov 26, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 078939-001 Jun 17, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 075095-001 Nov 30, 1999 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 075095-002 Nov 30, 1999 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 078939-002 Jun 17, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.